1470 — Evertex Fabrinology Balance Sheet
0.000.00%
- TWD2.22bn
- TWD1.85bn
- TWD788.04m
- 82
- 43
- 60
- 70
Annual balance sheet for Evertex Fabrinology, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 385 | 358 | 407 | 445 | 406 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 128 | 129 | 68.9 | 55.6 | 69.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 695 | 800 | 702 | 656 | 662 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 471 | 448 | 428 | 421 | 392 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,173 | 1,255 | 1,145 | 1,145 | 1,212 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 198 | 244 | 166 | 149 | 167 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 207 | 249 | 172 | 160 | 177 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 966 | 1,006 | 973 | 985 | 1,035 |
Total Liabilities & Shareholders' Equity | 1,173 | 1,255 | 1,145 | 1,145 | 1,212 |
Total Common Shares Outstanding |